Customized research for RCUS vs. DRNA!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for RCUS vs. DRNA.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Arcus Biosciences Inc. vs. Dicerna Pharmaceuticals, Inc.

Industry Match! Industry of Both RCUS and DRNA:

Health Care/Life Sciences

RCUS
Data Last Updated: More than a wk ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 482.959M


P/E: N/A

P/S: 32.2

Q P/B: 2.95

Y Rev: 15M

Q Rev: 9.75M

Beta: -0.61

RCUS Share Stats

Outstanding Shares

45.97M

Float Shares

27.08M

Percent of Float Short

5.62%

RCUS Insider Stats

Percent Outstanding Insider Ownership

1.4%

Percent Outstanding Institution Ownership

16.06%

RCUS Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

RCUS in Pulse Portal

Stream of Posts

RCUS Symbol Page

Share RCUS Insights

Express Sentiment

'Buy' or 'Sell' RCUS

RCUS Profile

CEO

Dr. Terry J. Rosen

Exchange

NYSE

Employees

139.00

About

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded...

RCUS Financials

Annual Financials

Income Statement

Revenue

15M

Net Income

(84.71M)

Cash Flow Statement

Change in Cash / Investments

(13.13M)

Balance Sheet

Cash / Investments

188.27M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

192.71M

Total Current Liabilities

22.71M

Total Assets

203.11M

Total Liabilities

39.27M

Stockholder Equity

163.84M

Quarterly Financials

Income Statement

Q Revenue

9.75M

Q Net Income

(16.6M)

Cash Flow Statement

Q Change in Cash / Investments

(21.06M)

Balance Sheet

Q Cash / Investments

188.27M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

192.71M

Q Total Current Liabilities

22.71M

Q Total Assets

203.11M

Q Total Liabilities

39.27M

Q Stockholder Equity

163.84M

RCUS Charts

10-Year Chart

RCUS 10-Year Chart

5-Year Chart

RCUS 5-Year Chart

1-Year Chart

RCUS 1-Year Chart

6-Month Chart

RCUS 6-Month Chart

3-Month Chart

RCUS 3-Month Chart

1-Month Chart

RCUS 1-Month Chart

1-Day Chart

RCUS 1-Day Chart

DRNA
Data Last Updated: More than a wk ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 1.119B


P/E: N/A

P/S: 46.82

Q P/B: 7.35

Y Rev: 23.9M

Q Rev: 7.08M

Beta: 2.36

DRNA Share Stats

Outstanding Shares

73.75M

Float Shares

60.95M

Percent of Float Short

5.03%

DRNA Insider Stats

Percent Outstanding Insider Ownership

0.32%

Percent Outstanding Institution Ownership

32.32%

DRNA Social Stats

Followers

2

B/S Rating Today

0

B/S Rating All-Time

+1

More Social Data

DRNA in Pulse Portal

Stream of Posts

DRNA Symbol Page

Share DRNA Insights

Express Sentiment

'Buy' or 'Sell' DRNA

DRNA Profile

CEO

Dr. Douglas M. Fambrough

Exchange

Nasdaq

Employees

187.00

About

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The firm uses its proprietary GalXC RNAi...

DRNA Financials

Annual Financials

Income Statement

Revenue

23.9M

Net Income

(120.46M)

Cash Flow Statement

Change in Cash / Investments

101.73M

Balance Sheet

Cash / Investments

348.88M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

556.17M

Total Current Liabilities

241.74M

Total Assets

597.41M

Total Liabilities

445.21M

Stockholder Equity

152.2M

Quarterly Financials

Income Statement

Q Revenue

7.08M

Q Net Income

(39.67M)

Cash Flow Statement

Q Change in Cash / Investments

105.94M

Balance Sheet

Q Cash / Investments

348.88M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

556.17M

Q Total Current Liabilities

241.74M

Q Total Assets

597.41M

Q Total Liabilities

445.21M

Q Stockholder Equity

152.2M

DRNA Charts

10-Year Chart

DRNA 10-Year Chart

5-Year Chart

DRNA 5-Year Chart

1-Year Chart

DRNA 1-Year Chart

6-Month Chart

DRNA 6-Month Chart

3-Month Chart

DRNA 3-Month Chart

1-Month Chart

DRNA 1-Month Chart

1-Day Chart

DRNA 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon